Bowel Gas Detection Device for Laparoscopic Colectomy Procedures
Trial Summary
What is the purpose of this trial?
Undetected bowel perforation is a rare but dangerous complication of laparoscopic surgery. If the injury is not detected and treated at the time of the surgical procedure, the patient can suffer severe complications, including septic shock and eventually death. The investigator's goal is to test a novel device that can detect bowel gas leakage from perforation and alert the surgeon during the operation by evaluating the gases present in the insufflated abdomen during surgery. This study will determine the ability of the device to be attached to a standard trocar during the operation and periodically draw small samples or aliquots of gas from the abdomen to evaluate the gas and accurately detect gaseous content from the bowel. Before the device can be used to detect bowel perforations, the investigators must first ensure that it can accurately detect bowel gas in an insufflated abdomen.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the Bowel Gas Detection Device, Perf-AlertTM, for laparoscopic colectomy procedures?
How does the Bowel Gas Detection Device treatment differ from other treatments for bowel conditions?
The Bowel Gas Detection Device is unique because it focuses on detecting and analyzing bowel gas during laparoscopic colectomy procedures, which can help assess and manage functional bowel disorders. Unlike other treatments that may focus on symptoms or surgical interventions, this device provides real-time information about gas distribution, potentially improving surgical outcomes and postoperative recovery.13567
Research Team
Alessio Pigazzi, MD,PhD
Principal Investigator
Weill Medical College of Cornell University
Eligibility Criteria
This trial is for adults over 18 who need elective laparoscopic right colectomy with intracorporeal anastomosis and can give informed consent. It's not for non-English speakers, emergency cases, peritoneal dialysis patients, those with abdominal infections or fistulas, or pregnant/breastfeeding individuals.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Surgical Procedure
Participants undergo laparoscopic right colectomy with intracorporeal anastomosis while the novel device is tested for detecting bowel gas leakage.
Follow-up
Participants are monitored for safety and effectiveness after the surgical procedure.
Treatment Details
Interventions
- Bowel Gas Detection Device
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor
Sentire Medical Systems
Collaborator